Announcement on Voluntary Disclosure of Acceptance of Marketing Application Regarding Additional Indication for Pegasus Interferon α-2 Injection

About this update from Beijing Kawin Technology Share-holding Co., Ltd. Class A

Announcement on Voluntary Disclosure of Acceptance of Marketing Application Regarding Additional Indication for Pegasus Interferon α-2 InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Beijing Kawin Technology Share-holding Co., Ltd. Class A